A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Bevacizumab
Sponsor: Hoffmann-La Roche